Skip to main content

Dicyclomine Dosage Information

Last reviewed: December 2025

Standard Adult Dosage

The typical starting dosage of dicyclomine for adults with irritable bowel syndrome is:

Initial dose:

  • 20 mg four times daily (80 mg total per day)
  • Taken orally

Dosage adjustment:

  • After one week, if tolerated and if needed, the dose may be increased to 40 mg four times daily (160 mg total per day)
  • This increase should only occur under healthcare provider guidance

Important: The 40 mg dose should only be used if the 20 mg dose is tolerated without significant side effects. Many patients respond to the 20 mg dose.

Maximum Daily Dosage

Maximum recommended dose:

  • 160 mg per day (40 mg four times daily)
  • Should not be exceeded

Safety note: If the condition does not improve after 2 weeks at the maximum dose, or if side effects require doses below 80 mg per day, the healthcare provider may consider discontinuing dicyclomine and exploring alternative treatments.

Timing of Doses

Dicyclomine is typically taken:

Frequency:

  • Four times daily
  • At evenly spaced intervals

Relationship to meals:

  • Generally taken before meals and at bedtime
  • Food may delay absorption but does not significantly affect overall effectiveness
  • Taking with food may reduce stomach upset

Typical schedule example:

  • Before breakfast
  • Before lunch
  • Before dinner
  • At bedtime

Available Forms and Strengths

Dicyclomine is available in several forms:

Oral capsules:

  • 10 mg capsules (blue)

Oral tablets:

  • 20 mg tablets (blue, round)

Oral syrup:

  • 10 mg per 5 mL solution

Injectable:

  • 10 mg/mL solution (intramuscular use only, not for home use)

The oral tablet and capsule forms are most commonly prescribed for outpatient use.

Children’s Dosing

Infants under 6 months:

  • Dicyclomine is CONTRAINDICATED (should not be used)
  • Serious adverse reactions including seizures, syncope, respiratory symptoms, and death have been reported

Children 6 months and older:

  • The safety and efficacy in pediatric patients have not been established
  • Use in children is not routinely recommended
  • If prescribed, dosing must be determined by a healthcare provider based on age, weight, and clinical situation

Older Adults

Older adults may be more susceptible to anticholinergic side effects:

Considerations:

  • May need to start at lower doses
  • Closer monitoring for side effects recommended
  • Watch for confusion, sedation, constipation, urinary retention
  • Heat intolerance may be more pronounced
  • May need to avoid or use with extreme caution

The American Geriatrics Society Beers Criteria lists anticholinergics like dicyclomine as potentially inappropriate for older adults due to increased sensitivity to side effects.

Dose Adjustments for Medical Conditions

Liver Disease

  • Specific dosage adjustments are not provided in labeling
  • Use with caution
  • May need dose reduction based on clinical response and tolerability
  • Monitor for increased side effects

Kidney Disease

  • Specific dosage adjustments are not provided in labeling
  • Use with caution in patients with renal impairment
  • Monitor for accumulation of effects

Autonomic Neuropathy

  • Use with caution
  • May have increased sensitivity to anticholinergic effects
  • Lower doses may be needed

Drug Interactions Affecting Dosing

Certain medications may interact with dicyclomine and affect how it should be dosed:

Medications that may enhance anticholinergic effects:

  • Other anticholinergic drugs
  • Antihistamines (especially first-generation)
  • Tricyclic antidepressants
  • Phenothiazines
  • MAO inhibitors

Medications that may be affected by dicyclomine:

  • Digoxin (increased absorption with slow-dissolving forms)
  • Other medications requiring gastric acidity for absorption

When taking these medications together, healthcare providers may adjust doses or monitor more closely.

Duration of Treatment

Short-term use:

  • May be used during IBS flare-ups
  • Symptom-based treatment for acute episodes

Ongoing use:

  • Continued use should be regularly evaluated
  • If no improvement after 2 weeks at maximum dose, consider discontinuation
  • Long-term use requires periodic reassessment of need and side effects

Missed Dose

If you miss a dose of dicyclomine:

  • Take the missed dose as soon as you remember
  • If it is almost time for your next dose, skip the missed dose
  • Do not double up to make up for a missed dose
  • Continue with your regular dosing schedule

What If It Doesn’t Work?

If dicyclomine does not adequately control symptoms:

Do not:

  • Exceed the maximum recommended dose (160 mg/day)
  • Continue indefinitely without improvement
  • Assume more medication will solve the problem

Instead:

  • Discuss with your healthcare provider
  • Consider alternative or additional treatments
  • Evaluate dietary and lifestyle factors
  • Explore other IBS management strategies

Injectable Form

The injectable form of dicyclomine:

  • Is for intramuscular use only (NOT intravenous)
  • Is typically used in clinical settings for patients who cannot take oral medication
  • Dose: 10-20 mg intramuscularly four times daily
  • Should not be used for more than 1-2 days
  • Oral therapy should replace injectable as soon as possible

Storage

  • Store at controlled room temperature (59°F to 86°F or 15°C to 30°C)
  • Protect from moisture
  • Keep in original container
  • Keep out of reach of children
  • Do not use after expiration date

When to Contact a Healthcare Provider

Consult your healthcare provider about dosing if:

  • Symptoms do not improve after 2 weeks of treatment
  • Side effects are intolerable at the starting dose
  • You need to take other medications that may interact
  • You have liver or kidney problems
  • You are elderly and experiencing side effects
  • You are unsure about your dosing schedule
  • You experience any concerning symptoms

Sources

  • FDA-approved prescribing information for Bentyl (dicyclomine hydrochloride)
  • Clinical pharmacology references
  • American Geriatrics Society Beers Criteria
Last reviewed: December 2025